L Lang

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

W C Eckelman, W H Theodore, R E Carson, 2003, Neurology.

Development of fluorine-18-labeled 5-HT1A antagonists.

W C Eckelman, R E Carson, E Jagoda, 1999, Journal of medicinal chemistry.

PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635.

W C Eckelman, R E Carson, H Watabe, 2000, Nuclear medicine and biology.

Fluoro analogs of WAY-100635 with varying pharmacokinetics properties.

W C Eckelman, E Jagoda, W. Eckelman, 2000, Nuclear medicine and biology.

Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes.

M Der, W C Eckelman, E Jagoda, 2001, Journal of chromatography. B, Biomedical sciences and applications.